ABR disturbances in children with insulin dependent diabetes mellitus

G Niedzielska1, E Katska

  • 1Department of Paediatric Otolaryngology, Phoniatry and Audiology, Medical Academy, Lublin, Poland.

Insights

Diabetes mellitus can cause auditory pathway damage in children, even without detectable hearing loss. Auditory Brainstem Response (ABR) revealed stem conduction issues in young patients with diabetes.

Area of Science:

  • Otorhinolaryngology
  • Pediatrics
  • Endocrinology

Background:

  • Diabetes mellitus is associated with hearing disturbances.
  • Previous research is conflicting regarding the location of auditory pathway damage in diabetes.
  • The retrocochlear pathway and inner ear cells are implicated.

Purpose of the Study:

  • To determine the location of auditory pathway disturbances in children with diabetes mellitus.
  • To investigate auditory pathway function in insulin-treated diabetic children.

Main Methods:

  • Analysis of 37 insulin-treated children aged 6-18 years.
  • Application of pure-tone audiometry.
  • Utilized impedance audiometry and auditory brainstem response (ABR).

Main Results:

  • Conduction disturbances were observed within the auditory brainstem response (ABR) pathway.
  • These ABR abnormalities were present in children who had normal pure-tone audiometry results.
  • Suggests subclinical auditory pathway dysfunction.

Conclusions:

  • Diabetes mellitus can lead to retrocochlear auditory pathway disturbances in children.
  • Auditory Brainstem Response (ABR) is a sensitive tool for detecting early auditory pathway changes in diabetic children.
  • Early detection of auditory pathway dysfunction is crucial for diabetic pediatric patients.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...